Amsterdam - Delayed Quote EUR

Akzo Nobel N.V. (AKZA.AS)

Compare
58.22 -0.10 (-0.17%)
As of 4:02 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
10,694,000.00
10,668,000.00
10,846,000.00
9,587,000.00
8,530,000.00
--
Cost of Revenue
6,320,000.00
6,434,000.00
6,923,000.00
5,683,000.00
4,745,000.00
--
Gross Profit
4,374,000.00
4,234,000.00
3,923,000.00
3,904,000.00
3,785,000.00
--
Operating Expense
3,275,000.00
3,205,000.00
3,215,000.00
2,786,000.00
2,822,000.00
--
Operating Income
1,099,000.00
1,029,000.00
708,000.00
1,118,000.00
963,000.00
--
Net Non Operating Interest Income Expense
-62,000.00
-98,000.00
-39,000.00
-18,000.00
-69,000.00
--
Pretax Income
890,000.00
784,000.00
602,000.00
1,105,000.00
919,000.00
--
Tax Provision
255,000.00
296,000.00
214,000.00
246,000.00
241,000.00
--
Net Income Common Stockholders
588,000.00
442,000.00
352,000.00
829,000.00
630,000.00
--
Diluted NI Available to Com Stockholders
588,000.00
442,000.00
352,000.00
829,000.00
630,000.00
--
Basic EPS
3.45
2.59
2.01
4.48
3.29
--
Diluted EPS
3.43
2.58
2.01
4.46
3.28
--
Basic Average Shares
170,800.00
170,573.56
174,735.14
184,959.87
191,424.40
--
Diluted Average Shares
170,800.00
171,338.76
175,313.50
185,673.98
192,101.80
--
Total Operating Income as Reported
1,099,000.00
1,029,000.00
708,000.00
1,118,000.00
963,000.00
--
Total Expenses
9,595,000.00
9,639,000.00
10,138,000.00
8,469,000.00
7,567,000.00
--
Net Income from Continuing & Discontinued Operation
588,000.00
442,000.00
352,000.00
829,000.00
630,000.00
--
Normalized Income
624,820.22
475,612.00
374,900.00
823,000.00
637,000.00
--
Interest Income
--
102,000.00
54,000.00
28,000.00
28,000.00
--
Interest Expense
--
193,000.00
106,000.00
74,000.00
97,000.00
--
Net Interest Income
-62,000.00
-98,000.00
-39,000.00
-18,000.00
-69,000.00
--
EBIT
1,108,000.00
977,000.00
708,000.00
1,179,000.00
1,016,000.00
--
EBITDA
1,471,000.00
1,334,000.00
1,076,000.00
1,530,000.00
1,377,000.00
--
Reconciled Cost of Revenue
6,320,000.00
6,434,000.00
6,923,000.00
5,683,000.00
4,745,000.00
--
Reconciled Depreciation
363,000.00
357,000.00
368,000.00
351,000.00
361,000.00
--
Net Income from Continuing Operation Net Minority Interest
592,000.00
447,000.00
362,000.00
823,000.00
637,000.00
--
Total Unusual Items Excluding Goodwill
-46,000.00
-46,000.00
-20,000.00
--
--
--
Total Unusual Items
-46,000.00
-46,000.00
-20,000.00
--
--
--
Normalized EBITDA
1,517,000.00
1,380,000.00
1,096,000.00
1,530,000.00
1,377,000.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-13,179.78
-17,388.00
-7,100.00
--
--
--
12/31/2019 - 3/27/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AKE.PA Arkema S.A.
80.25
-1.59%
 
IMCD.AS IMCD N.V.
148.75
-0.07%
 
WCH.DE Wacker Chemie AG
82.22
-1.04%
 
AZE.BR Azelis Group NV
18.72
-0.48%
 
EVK.DE Evonik Industries AG
19.81
+0.33%
 
DSFIR.AS DSM-Firmenich AG
119.10
+0.25%
 
CLN.SW Clariant AG
12.72
-0.24%
 
BNR.DE Brenntag SE
64.48
-1.20%
 
OCI.AS OCI N.V.
28.47
-0.25%
 
AVTX.AS Avantium N.V.
1.8120
+0.22%